COG Biospecimen Bank

COG 生物样本库

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The Children's Oncology Group (COG) is the pediatric clinical trials group of the National Clinical Trials Network (NCTN). Over 90% of United States and Canadian children and adolescents with cancer are treated at COG institutions with no racial, ethnic or geographic bias to registration, allowing for near-population-based clinical, translational and basic research. COG has established a strong track record of collecting and banking tumor and non-diseased biospecimens from patients enrolled in COG-sponsored clinical trials, most of which include randomized treatment questions. The COG Biospecimen Bank (COG BB), located within the Biopathology Center at Nationwide Children's Hospital, aims to provide high-quality pediatric and adolescent human malignant biospecimens to the research community. Annually, the COG BB receives and banks over 100,000 specimens from approximately 5,500 COG patients from over 225 COG institutions, and distributes approximately 10,000 specimens to approved investigators. The bank also offers services such as nucleic acid isolations, pathology review, virtual microscopy, clinical reference laboratory testing, and informatics initiatives. This proposal supports the collection, processing, and distribution of biospecimens from patient enrolled on COG Phase III and large Phase II trials (approximately 4,000 patients per year). The COG BB seeks to directly promote and support outstanding research in the diagnosis and treatment of pediatric cancer through centralized collection, quality control, storage, and distribution procedures. The COG BB will continue efforts to provide the latest biorepository based technological innovations and best practices, resulting in constant improvements in our operational capabilities, investigator access to biospecimens, investigator satisfaction, and the stewardship of these precious resources. Under proper regulatory guidelines and in association with the COG Statistical and Data Center, the COG BB will support translational aspects of cutting-edge research by ensuring appropriate tracking of biospecimens as well as linkages to existing demographic, clinical, biological, treatment, and outcome data. Finally the COG BB will provide investigators with a comprehensive database solution and dynamic informatics tools that facilitate pediatric cancer research, including the use of the Biospecimen IT Navigator and the NCTN Biospecimen front door services.
 描述(申请人提供):儿童肿瘤学小组(COG)是国家临床试验网络(NCTN)的儿科临床试验小组。超过90%的美国和加拿大癌症儿童和青少年在COG机构接受治疗,没有种族、民族或地理上的登记偏见,允许进行几乎基于人群的临床、转化和基础研究。COG在收集和储存参加COG赞助的临床试验的患者的肿瘤和非疾病生物标本方面建立了良好的记录,这些试验大多包括随机治疗问题。COG生物谱库(COG BB)位于全国儿童医院生物病理学中心内,旨在为研究界提供高质量的儿童和青少年人类恶性生物谱库。每年,COG BB从来自225多个COG机构的大约5500名COG患者那里接收并储存超过10万份标本,并将大约10,000份标本分发给经批准的研究人员。该银行还提供诸如核酸分离、病理检查、虚拟显微镜、临床参考实验室测试和信息学倡议等服务。这项建议支持收集、处理和分发参加COG III期和大型II期试验(每年约4000名患者)的患者的生物标记物。COG BB寻求通过集中收集、质量控制、存储和分发程序,直接促进和支持儿科癌症诊断和治疗方面的杰出研究。COG BB将继续努力提供最新的基于生物库的技术创新和最佳实践,从而不断提高我们的操作能力、研究人员获得生物显微镜的机会、调查人员的满意度以及这些宝贵资源的管理。在适当的法规指导下,并与COG统计和数据中心合作,COG BB将通过确保适当跟踪生物样本以及与现有人口、临床、生物、治疗和结果数据的联系,支持尖端研究的翻译方面。最后,COG BB将为研究人员提供全面的数据库解决方案和动态信息学工具,以促进儿科癌症研究,包括使用Biosecimen IT Navigator和NCTN Biospecimen前门服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie M Gastier-Foster其他文献

Addressing the childhood cancer crisis in sub-Saharan Africa
应对撒哈拉以南非洲地区的儿童癌症危机
  • DOI:
    10.1016/s1470-2045(23)00173-0
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
    35.900
  • 作者:
    Joseph Lubega;Lulu Chirande;Barnabas Atwine;Alan Davidson;Heronima J Kashaigili;Aimable Kanyamuhunga;Robert K Langat;Deogratias Munube;Rizine Mzikamanda;Ruth Namazzi;Irene Nzamu;Anne Akullo;Carl Allen;Julie M Gastier-Foster;Marilyn Hockenberry;Nmazuo Ozuah;Peter Wasswa;Rachel Smith;Kristi Wilson-Lewis;David G Poplack
  • 通讯作者:
    David G Poplack
DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features
  • DOI:
    10.1182/blood-2022-163728
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Nicole Thomas;Kostiantyn Dreval;Daniela S. Gerhard;Laura K Hilton;Jeremy S. Abramson;Nancy L. Bartlett;Jeffrey Bethony;Jay Bowen;Anthony Bryan;Corey Casper;Maureen Dyer;Manel Esteller;Carlos Garcia-Prieto;Julie M Gastier-Foster;Alina S. Gerrie;Bruno M. Grande;Timothy C. Greiner;Nicholas B. Griner;Thomas G. Gross;Nancy Lee Harris
  • 通讯作者:
    Nancy Lee Harris

Julie M Gastier-Foster的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie M Gastier-Foster', 18)}}的其他基金

Diagnostics & Laboratory Core
诊断
  • 批准号:
    10223900
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
  • 批准号:
    10427346
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
  • 批准号:
    10657497
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
Diagnostics & Laboratory Core
诊断
  • 批准号:
    10657485
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
  • 批准号:
    10223902
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
Diagnostics & Laboratory Core
诊断
  • 批准号:
    10427344
  • 财政年份:
    2020
  • 资助金额:
    $ 224.49万
  • 项目类别:
COG Biospecimen Bank
COG 生物样本库
  • 批准号:
    8913447
  • 财政年份:
    2015
  • 资助金额:
    $ 224.49万
  • 项目类别:
SWOG Biospecimen Bank
SWOG 生物样本库
  • 批准号:
    9252983
  • 财政年份:
    2015
  • 资助金额:
    $ 224.49万
  • 项目类别:
Diagnostics & Laboratory Core
诊断
  • 批准号:
    10084675
  • 财政年份:
  • 资助金额:
    $ 224.49万
  • 项目类别:
Improving the Accuracy of Diagnosis of Cancer in Children with HIV Infection
提高 HIV 感染儿童癌症诊断的准确性
  • 批准号:
    10084677
  • 财政年份:
  • 资助金额:
    $ 224.49万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 224.49万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 224.49万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了